DK671087A - Anvendelse af 5-aryl-3h-1,2,4-triazol-3-oner som antikonvulsiva - Google Patents

Anvendelse af 5-aryl-3h-1,2,4-triazol-3-oner som antikonvulsiva

Info

Publication number
DK671087A
DK671087A DK671087A DK671087A DK671087A DK 671087 A DK671087 A DK 671087A DK 671087 A DK671087 A DK 671087A DK 671087 A DK671087 A DK 671087A DK 671087 A DK671087 A DK 671087A
Authority
DK
Denmark
Prior art keywords
triazol
aryl
ones
anticonvulsive
anticonvulsants
Prior art date
Application number
DK671087A
Other languages
English (en)
Other versions
DK671087D0 (da
DK172661B1 (da
Inventor
Francis P Miller
John M Kane
Original Assignee
Merrell Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Pharma Inc filed Critical Merrell Pharma Inc
Publication of DK671087D0 publication Critical patent/DK671087D0/da
Publication of DK671087A publication Critical patent/DK671087A/da
Application granted granted Critical
Publication of DK172661B1 publication Critical patent/DK172661B1/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C07D249/10—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D249/12—Oxygen or sulfur atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Photoreceptors In Electrophotography (AREA)
  • Lubricants (AREA)
DK198706710A 1986-12-19 1987-12-18 Anvendelse af 5-aryl-3H-1,2,4-triazol-3-oner til fremstilling af et farmaceutisk præparat til behandling af krampeanfald DK172661B1 (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US94463486A 1986-12-19 1986-12-19
US94463486 1986-12-19
US9031087A 1987-08-27 1987-08-27
US9031087 1987-08-27

Publications (3)

Publication Number Publication Date
DK671087D0 DK671087D0 (da) 1987-12-18
DK671087A true DK671087A (da) 1988-06-20
DK172661B1 DK172661B1 (da) 1999-05-03

Family

ID=26782142

Family Applications (1)

Application Number Title Priority Date Filing Date
DK198706710A DK172661B1 (da) 1986-12-19 1987-12-18 Anvendelse af 5-aryl-3H-1,2,4-triazol-3-oner til fremstilling af et farmaceutisk præparat til behandling af krampeanfald

Country Status (10)

Country Link
EP (1) EP0273310B1 (da)
JP (1) JP2542880B2 (da)
KR (1) KR960003326B1 (da)
AT (1) ATE123942T1 (da)
DE (1) DE3751362T2 (da)
DK (1) DK172661B1 (da)
ES (1) ES2076141T3 (da)
GR (1) GR3017358T3 (da)
IE (1) IE66265B1 (da)
PH (1) PH24094A (da)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4966909A (en) * 1989-12-20 1990-10-30 Merrell Dow Pharmaceuticals 4-benzyl-5-phenyl-2,4-dihydro-3H-1,2,4-triazol-3-ones and their use as anticonvulsants
DE19816882A1 (de) * 1998-04-17 1999-10-21 Boehringer Ingelheim Pharma Triazolone mit neuroprotektiver Wirkung
TW200505441A (en) 2003-03-24 2005-02-16 Hoffmann La Roche Non-nucleoside reverse transcriptase inhibitorsⅠ
ES2391461T3 (es) 2004-07-27 2012-11-27 F. Hoffmann-La Roche Ag Compuestos de benciltriazolona utilizados como inhibidores no nucleósidos de transcriptasa inversa
US8293778B2 (en) 2004-07-27 2012-10-23 Roche Palo Alto Llc Heterocyclic antiviral compounds
MX2009009920A (es) 2007-03-29 2009-10-19 Hoffmann La Roche Inhibidores no nucleosidos de transcriptasa inversa.
WO2013134562A1 (en) 2012-03-09 2013-09-12 Inception 2, Inc. Triazolone compounds and uses thereof
MX376108B (es) 2012-12-20 2025-03-07 Tempest Therapeutics Inc Compuestos de triazolona y usos de los mismos.
AU2014315151A1 (en) 2013-09-06 2016-03-03 Inception 2, Inc. Triazolone compounds and uses thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1126882B (de) * 1960-05-03 1962-04-05 Boehringer Sohn Ingelheim Verfahren zur Herstellung von 1,2,4-Triazolonen-(5)
BE621842A (da) * 1962-08-27
DE1545646B1 (de) * 1965-12-15 1969-09-18 Boehringer Sohn Ingelheim 1,3-Dimethyl-4-(2',4'-dichlorphenyl)-1,2,4-triazolon-(5) und Verfahren zu dessen Herstellung
DD153953A3 (de) * 1980-04-01 1982-02-17 Gottfried Schuster Mittel zur chemotherapie von virosen der kulturpflanzen
DD160447A1 (de) * 1981-03-26 1983-08-03 Johannes Dost Herbizide mittel, die 1,2,4-triazolinone-(5) enthalten
AR243171A1 (es) * 1985-10-29 1993-07-30 Merrell Pharma Inc Procedimiento para preparar 5-aril-2,4-dialquil-3h-1,2,4-triazol-3-tionas.

Also Published As

Publication number Publication date
KR880007494A (ko) 1988-08-27
ATE123942T1 (de) 1995-07-15
DK671087D0 (da) 1987-12-18
EP0273310B1 (en) 1995-06-21
PH24094A (en) 1990-03-05
JP2542880B2 (ja) 1996-10-09
EP0273310A2 (en) 1988-07-06
ES2076141T3 (es) 1995-11-01
IE873458L (en) 1988-06-19
EP0273310A3 (en) 1991-01-09
KR960003326B1 (ko) 1996-03-08
JPS63170313A (ja) 1988-07-14
DE3751362D1 (de) 1995-07-27
DE3751362T2 (de) 1996-02-29
DK172661B1 (da) 1999-05-03
GR3017358T3 (en) 1995-12-31
IE66265B1 (en) 1995-12-27

Similar Documents

Publication Publication Date Title
BR1100989A (pt) Composto e composição de matéria
IN172468B (da)
ES520340A0 (es) Un procedimiento para la preparacion de diarilpirazinas o triazinas.
DE3685633D1 (de) Behandlung von knochenstoerungen.
ES2018009B3 (es) Procedimiento para la fabricacion de aceites lubricantes.
DE3889416D1 (de) Wärmebeständiges Schmiermittel zur Behandlung von Kunstfasern.
DK671087D0 (da) Anvendelse af 5-aryl-3h-1,2,4-triazol-3-oner som antikonvulsiva
AU634003B2 (en) 4-benzyl-5-phenyl-2,4-dihydro-3h-1,2,4-triazol-3-ones and their use as anticonvulsants
DK0750616T3 (da) Syreadditionssalte af 2,3,4,5-tetrahydro-1H-3-benzazapinforbindelser
ITMI913465A1 (it) Procedimento per la depurazione dell'1, 1, 1-trifluoro-2-fluoroetano
FI873428A7 (fi) Silmälääketieteelliset koostumukset hermodegeneraatioiden hoitoon.
ATE28188T1 (de) Antikonvulsive mittel.
DE3879985D1 (de) Anticonvulsive agenzien.
DK671187D0 (da) Anvendelse af 5-aryl-3h-1,2,4-triazol-3-oner ved behandling af neurodegenerative sygdomme
DE3576689D1 (de) Oxa- und thiadiazolylderivate und ihre verwendung.
EP0116628A4 (en) 1-ACYL-3-PYRIDYLMETHYLGUANIDINE AND THEIR USE AS AN ANI-HYPERTENSIVE.
DK0544168T3 (da) Anvendelse af aminoalkyl-substituerede 5,6-dihydro-dibenz(b,e) azepin-6,11-dion-11-oximer som antivirale midler
ITMI930520A1 (it) Procedimento per la preparazione di disperdenti solfonati.
ATE90562T1 (de) Antiepileptisch wirkende pyrazolopyridine.
MX5413A (es) Procedimiento para la preparacion de n-benzoil-n'-fenilureas.
ES2016651B3 (es) Proceso mejorado para la preparacion de n,n'tetratiodimorfolinas.
DE3880110D1 (de) Herstellung von m-aminophenol.
ES553789A0 (es) Nuevo procedimiento para la fabricacion de n,n-((3,5-diacetamido-2,4,6-tryodobenzoil)-sarcosil)-n-metilglucamida.
DE69111209D1 (de) Herstellung und Reinigung von 3,4-Dihydrocumarin.
ES550849A0 (es) Procedimiento para la oxidacion de ciclohexano.

Legal Events

Date Code Title Description
B1 Patent granted (law 1993)
PBP Patent lapsed